first

Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers

- Stenoparib clinical development continues in relapsed small cell lung cancer and, under FDA Fast Track designation, in advanced ovarian…

1 month ago

AION V Achieves Another Milestone: Global Sales Up 179% in April, Ranks First in J.D. Power Compact BEV APEAL Study

GUANGZHOU, China, May 15, 2026 /PRNewswire/ -- In April of this year, AION V saw a 179% year-over-year increase in global…

1 month ago

Oncotelic Therapeutics Files First Quarter 2026 Financial Results and Strategic Progress

Agoura Hills, Calif., May 15, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“Oncotelic” or the “Company”), a clinical-stage…

1 month ago

Vaso Corporation Announces Financial Results for First Quarter of 2026

May 15, 2026 09:00 ET  | Source: Vaso Corporation PLAINVIEW, N.Y., May 15, 2026 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”)…

1 month ago

Cypherpunk Technologies Reports First Quarter 2026 Financial Results

CAMBRIDGE, Mass., May 14, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the first…

1 month ago

ABB is first in world to offer a magnet-free IE6 motor for hazardous areas

Boosting energy efficiency in hazardous areas is critical for operators seeking to reduce their operating costs while also meeting sustainability…

1 month ago

THE ROYAL MINT SHINES A LIGHT ON PINK FLOYD WITH FIRST EVER UK COMMEMORATIVE COIN

LLANTRISANT, Wales, May 14, 2026 /PRNewswire/ -- More than half a century since Pink Floyd first emerged from the London…

1 month ago

Aptose Reports First Quarter 2026 Results

SAN DIEGO and TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS and…

1 month ago

ZyVersa Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal diseases with a total accessible market >$100 billion.Inflammasome…

1 month ago

Exterro Launches Industry’s First Autonomous AI Engine to Eliminate Up to 95% of manual Subpoena Work and Reclaim 7,500 Enterprise Hours

Exterro Subpoena Manager unlocks $500,000+ in potential annual savings; puts legal and IT teams on a definitive path toward a…

1 month ago